Prostate-Specific Membrane Antigen-Targeted Antibody–Drug Conjugates: A Promising Approach for Metastatic Castration-Resistant Prostate Cancer
Prostate cancer (PCa), especially metastatic castration-resistant prostate cancer (mCRPC), is a significant cancer characterized by its poor prognosis and limited treatment options. Prostate-specific membrane antigen (PSMA) has emerged as a diagnostic and therapeutic target for PCa due to its restri...
Saved in:
| Main Authors: | Chia-Hsien Shih, Tzuo-Yi Hsieh, Wen-Wei Sung |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/7/513 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Distant ureteric metastasis of prostate cancer four years post radical prostatectomy
by: Sachin J. Joshi, et al.
Published: (2025-03-01) -
Prostate cancer with synchronous metastatic penile lesion: A case report
by: Muhammad Fajar, et al.
Published: (2025-09-01) -
Transperineal US-Guided Biopsy in Metastatic Prostate Cancer with Low Prostate Specific Antigen: A Case Report
by: Seongeun Jung, et al.
Published: (2025-05-01) -
Therapy results of patients with metastatic castration‑resistant prostate cancer. Regional experience
by: P. G. Berezin, et al.
Published: (2023-03-01) -
Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer
by: Himisha Beltran, et al.
Published: (2025-08-01)